Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Brentuximab Vedotin in the Prevention of Graft-Versus-Host Disease (GVHD) After Unrelated Allogeneic Stem Cell Transplantation

NCT01700751 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT01700751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01700751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Brentuximab Vedotin in the Prevention of Graft-Versus-Host Disease (GVHD) After Unrelated Allogeneic Stem Cell Transplantation
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Completed
Start date
February 25, 2013
Completion date
November 21, 2016
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, acute myeloid, leukemia, lymphoblastic,acute, myelodysplastic syndromes